Sildenafil citrate is the first phosphodiesterase type 5 (PDE-5) inhibitor approved by Food and Drug Administration (1998). PDE-5 inhibition causes an elevation in intracellular cGMP level as cGMP is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback